Status:
COMPLETED
Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)
Lead Sponsor:
Medtronic Cardiovascular
Conditions:
Aneurysm
Aortic Aneurysm
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess the benefits of endovascular repair with Endurant Stent Graft System by documenting overall mortality, complications, the rate of conversion to open surgical rep...
Detailed Description
Data regarding the use under routine practice of abdominal aortic stent grafts in France are expected by the French National Authority for Health (HAS). Therefore, in its opinion report from July 13, ...
Eligibility Criteria
Inclusion
- Patient with age ≥18 years, who is able to understand the information given by the investigator regarding the collection and release of his/her personal information and who is able to oppose to this collection and release.
- Any patient requiring placement of an abdominal aortic stent graft for the treatment of a non-ruptured infra-renal abdominal aortic aneurysm.
- Patient not opposed to the collection and release of his/her personal information
- Intention of physician to implant electively the Endurant™ Stent Graft System
Exclusion
- Patient in whom clinical follow-up will not be possible i.e. patient not able to come back for follow-up visits (ex. patient living abroad)
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 21 2018
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01526811
Start Date
March 1 2012
End Date
December 21 2018
Last Update
November 2 2021
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier d'Avignon
Avignon, France, 84902
2
CHU de Besancon, Hôpital Jean Minjoz
Besançon, France, 25030
3
Médipôle de Savoie
Challes-les-Eaux, France, 73190
4
Hôpital Privé Sainte Marie
Chalon-sur-Saône, France, 71100